The research was made possible in part by an endowing USPOULTRY Foundation gift from Cargill and proceeds from the International Poultry Expo, part of the International Production & Processing Expo.
The expected long-term impact of the study was to help poultry breeders selectively breed chickens to have the most effective AvBD1 genotype, reduce the Salmonella population within the chicken gut and ultimately produce a safer poultry product.
Findings showed that vaccination with BBS 866 or AviPro Megan Egg significantly reduced colonization by S. Reading in turkeys, indicating that these vaccines are cross-protective and could be a pre-harvest intervention strategy against this serovar.
As of Dec. 14, 2022, CDC announced that the outbreak is over. CDC reports a total of 39 illnesses in four states, and the last illness onset was Oct. 23, 2022.